Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003
The relationship between thyroid hormones, somatomedin-C (IGF-1), anabolic hormones and the severity of disease in chronic obstructive lung disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006
Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure Source: Eur Respir J 2004; 24 : 615-623 Year: 2004
Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways Source: Eur Respir J 2013; 41: 1116-1125 Year: 2013
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension}, Source: Eur Respir J 2012; 40: 895-904 Year: 2012
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases Source: Eur Respir J 2008; 31: 343-348 Year: 2008
The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Vasoactive intestinal peptide (VIP) markedly attenuates pulmonary hypertension in fawn-hooded rats Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005
Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018 Year: 2018
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005
Influence of treatment on leptin levels in patients with obstructive sleep apnoea Source: Eur Respir J 2004; 23: 601-604 Year: 2004
R667 retinoid agonist modulates blood glucose in COPDe patients with improved metabolic profile compared to ATRA Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Oral steroids induce leptin and adiponectin in subjects with airway obstructive diseases Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: 1130-1137 Year: 2002
Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 858-863 Year: 2005
Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment Source: Eur Respir J 2011; 38: 851-860 Year: 2011
Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 485s Year: 2001